FDA+ roundup: Sen. Tillis goes after Biden administration for supporting march-in rights

Sen. Thom Tillis (R-NC) is pushing back on the Biden administration’s plans for how it hypothetically would use its controversial “march-in” authority when drug prices become too high.

The Biden administration in December unveiled a framework that laid out how the federal government would…
Click here to view original post